Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Oct. 11, 2011

View Archived Issues

New heart valves challenge Edwards in transapical space

PARIS — Europe is back on the frontlines in the development of transcatheter aortic valve implantation (TAVI). (Medical Device Daily) Read More

Greater surgeon control key to new TAVI valves

Washington roundup: Parallel review pilot: just a new saddle on an old nag?

HIT seen as the hottest investment in healthcare

Financings roundup: Zeltiq seeks to raise $128M through IPO

HIT roundup: St. Jude launches new version of Merlin.net

Coming Wednesday in MDD Perspectives: A really bad idea: FDA conducting CE research

Agreements/contracts: Maquet Cardio to supply intra-aortic balloon pumps

Patent watch: Bovie gets electrosurgical leakage device approval

Med-Tech Notes

People in the News

Product Briefs

MDD's Cardio Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...